Frasers Centrepoint Trust – Early recovery for suburban malls October 29, 2021 989

PSR Recommendation: BUY Status: Maintained
Target Price: 2.83
  • FY21 NPI of S$246.6mn (+122.4%) and DPU of 12.085 cents (+33.7%) were in line, forming 96% and 99% of our estimates.
  • S$9mn in rental rebates provided in FY21, one-third of that provided in FY20.
  • Occupancy and NPI margins back to pre-pandemic levels, positive reversions at six out of nine malls.
  • Reiterate BUY, DDM TP (COE 6.38%) lowered from S$2.87 to S$2.83. We lower our FY22e-25e DPU by 5.8%-6.6% to factor in a more conservative pace of rental growth. Catalysts expected from growth in mall catchment, asset enhancement and M&A/collaboration opportunities.

 

The Positives

+ NPI margin back at pre-pandemic levels.  FY21 NPI margins improved YoY from 67.5% to 72.3% due to cost-containment initiatives and lower marketing cost due to absence of atrium events. Historical NPI margins have tracked between 70%-72%. FCT was able to trim operating cost through various initiatives such as employing central security office to reduce manpower costs. The absence of atrium sales also reduced marketing expense. As restrictions on use of atrium space is lifted, increased marketing cost should be offset by returning atrium revenues, keeping NPI margins stable.

+ Retail occupancy up 0.9ppt YoY to 97.3%. Occupancy has normalised to pre-pandemic levels, up from FCT’s low of 94.6% a year ago. Occupancy improved across six out of nine of FCT’s malls. FCT has begun renewal discussions the 35.7% of GRI expiring in FY22. c.25% of these leases are currently in advanced stages of negotiation or in the documentation phase.

 

The Negatives

– Retail reversions landed in the red. Full year reversions were -0.6%, weighed down by negative reversions at Changi City Point, Century Square and Tampines 1 which came in at -9.8%, -2.8% and -0.1% respectively. Changi City Point was affected by weaker demand as the asset is located near business parks and the Singapore Expo and impacted by lower footfall due to the WHF and absence of trade show and events. FY21 expiries for Century Square were high at c.40% as many tenants were signed after the mall was repositioned three years ago. The unfortunate timing of lumpy expiries during the pandemic has led to a slower absorption of space. The remaining six out of nine malls registered positive reversions ranging 0.3% to 2.5%. FCT’s only office asset, Central Plaza, also registered positive reversions of 1.9%. As retail leases typically include rental step-ups during the lease term. Reversions on average incoming vs average outgoing rents were +2.1%, implying rental growth over the next three years.

– Slight decline in portfolio valuation. Portfolio valuation dipped S$8mn or 0.1% of AUM YoY. Causeway point registered a $S7mn increase in valuation, 1.1% above its pre-pandemic valuation. Decline in valuation was attributed to two assets – Changi City Point and Yishun 10 Retail podium – due to the pandemic situation. Yishun 10 houses cinema operator Golden Village. Capacity constrains in cinema halls have also reduced the footfall for the asset and could have resulted in weaker leasing. Valuations for the remaining six out of nine malls were unchanged, keeping their pre-pandemic valuations.

– July and September tenant sale dipped to 93% and 98% of 2019 levels due to restrictions on group size and in-restaurant dining. We note that FCT’s tenant sales underperform the RSI (ex MV) in periods of tightened restrictions as consumers tend towards e-commerce and avoid crowded places.

 

Outlook

Stronger demand from F&B retailers. FCT noted strong leasing demand from F&B retailers, stemming from new-to-market brands and expansions. However, care has been taken so as not to crowd the malls with too many F&B offerings in the interest of preserving the retail diversity and preventing cannibalisation amongst F&B tenants. Apart from F&B, FCT has also received interest from fashion retailers and grocers. Consolidation and relocation amongst tenants are par for the course, but FCT has dealt with such circumstances opportunistically. For instance, the exit of a mini-anchor tenants at Waterway Point allowed FCT to relocate Toys R Us to the second floor, creating a kids’ zone, while Toys R Us’ vacated space was taken up by Don Don Donki, creating a value zone.

Healthy occupancy cost points to sustainability of rents. Occupancy cost measures tenants’ cost of maintaining a physical store relative to the amount of revenue generated by the store. It has trended between 15.7% to 17.0% from FY16-19 but spiked to 19% in FY20. Occupancy cost dipped to 17.5% in FY21, implying a more sustainable level of rents to further rental growth as reopening progresses.

 

Maintain BUY, TP lowered from S$2.87 to S$2.83

We lower our FY22e-25e DPU by 5.8%-6.6% to factor in a more conservative pace of rental growth. We reiterate our BUY recommendation. We believe suburban mall will remain relevant and resilient due to their proximity to household catchments and the resilience of necessity-driven spending. Current price implies FY22e/23e DPU yield of 5.5%/5.7%.

 

Demand for space in dominant mall remains healthy while sustained reopening visibility should support leasing and rental growth, in our view. FCT’s portfolio of well-located suburban malls are expected to draw a disproportionate share of leasing demand.

 

Catalysts include asset-enhancement initiatives, acquisitions from its sponsor’s pipeline of assets, increasing its stake in Waterway Point, or acquiring or partnering companies with only one mall in their portfolios. The cost of implementing and maintaining loyalty programmes or omnichannel retailing is higher for single-mall owners, which may present acquisition opportunities.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!